i n f l a r x

Loading

Press Release

Home Investors Press Releases Press Release

InflaRx Announces Plans to Apply for Emergency Use Authorization from the US FDA for Vilobelimab for Treatment of Critically Ill COVID-19 Patients

Jul 26, 2022

Time to read 4 Minutes

Download PDF

Back